Jacob Marsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacob Marsh has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Celeste M. Karch
Department of Psychiatry, Washington University in St. Louis, St. Louis, USA
10 shared publications Rj Martinez
5 shared publicationsGuangming Huang
Department of Psychiatry, Washington University in St. Louis School of Medicine
3 shared publications- Miguel Minaya
Department of Psychiatry, Washington University in St Louis, St Louis, USA
3 shared publications - Arun Renganathan
Department of Psychiatry, Washington University in St Louis, St Louis, USA
2 shared publications Emma Starr
Washington University in St. Louis School of Medicine
2 shared publications
Latest Publications
- Open Access
Ms4a4a loss reprograms amyloid-associated microglia and limits dense-core plaque-associated tau spreading
INTRODUCTION: Microglia regulate amyloid plaque-associated microenvironments that contribute to downstream tau pathology in Alzheimer’s disease (AD). Variants within the MS4A locus are strongly associated with AD risk and resilience and are linked to microglial biology; however, the functional role of MS4A4A in plaque-associated tau pathology remains poorly understood. METHODS: Single-nucleus RNA sequencing (snRNA-seq) was performed on hippocampi from non-transgenic, Ms4a4a knockout (4A-KO), 5xFAD, and 5xFAD 4A-KO mice at 6 months of age. To assess plaque-associated tau pathology, AD-derived tau aggregates were injected into the hippocampus of 5xFAD and 5xFAD 4A-KO mice at 6 months, and histological analyses were performed 3 months later. RESULTS: Amyloid pathology was the dominant driver of microglial state transitions, while Ms4a4a loss selectively remodeled activated microglial transcriptional programs enriched for interferon, lysosomal, autophagic, and proteostatic pathways. Activated microglia from 5xFAD 4A-KO mice exhibited altered expression of genes linked to immune signaling and protein handling. Following AD-tau inoculation, Ms4a4a loss did not significantly alter overall phospho-tau burden but selectively reduced dense-core plaque-associated neuritic plaque tau (NP-tau), particularly in the contralateral hemisphere. This phenotype was strongest surrounding X-34-positive fibrillar plaques and occurred without major changes in plaque-associated microgliosis. DISCUSSION: These findings identify Ms4a4a as a regulator of plaque-associated microglial programs linked to NP-tau accumulation in the amyloid-bearing brain. More broadly, this work supports a model in which AD resilience-associated microglial pathways selectively shape plaque-associated microenvironments that promote downstream tau pathology.
Open AccessMs4a4a loss reprograms amyloid-associated microglia and limits dense-core plaque-associated tau spreading
INTRODUCTION: Microglia regulate amyloid plaque-associated microenvironments that contribute to downstream tau pathology in Alzheimer’s disease (AD). Variants within the MS4A locus are strongly associated with AD risk and resilience and are linked to microglial biology; however, the functional role of MS4A4A in plaque-associated tau pathology remains poorly understood. METHODS: Single-nucleus RNA sequencing (snRNA-seq) was performed on hippocampi from non-transgenic, Ms4a4a knockout (4A-KO), 5xFAD, and 5xFAD 4A-KO mice at 6 months of age. To assess plaque-associated tau pathology, AD-derived tau aggregates were injected into the hippocampus of 5xFAD and 5xFAD 4A-KO mice at 6 months, and histological analyses were performed 3 months later. RESULTS: Amyloid pathology was the dominant driver of microglial state transitions, while Ms4a4a loss selectively remodeled activated microglial transcriptional programs enriched for interferon, lysosomal, autophagic, and proteostatic pathways. Activated microglia from 5xFAD 4A-KO mice exhibited altered expression of genes linked to immune signaling and protein handling. Following AD-tau inoculation, Ms4a4a loss did not significantly alter overall phospho-tau burden but selectively reduced dense-core plaque-associated neuritic plaque tau (NP-tau), particularly in the contralateral hemisphere. This phenotype was strongest surrounding X-34-positive fibrillar plaques and occurred without major changes in plaque-associated microgliosis. DISCUSSION: These findings identify Ms4a4a as a regulator of plaque-associated microglial programs linked to NP-tau accumulation in the amyloid-bearing brain. More broadly, this work supports a model in which AD resilience-associated microglial pathways selectively shape plaque-associated microenvironments that promote downstream tau pathology.
- Open Access
The NORAD-pumilio regulatory axis links lncRNA dysregulation to tau propagation-associated phenotypes
Long non-coding RNAs (lncRNAs) are increasingly implicated in neurodegenerative disease, yet their roles in tauopathy remain poorly understood. Here, we defined the lncRNA landscape across iPSC-derived neurons, astrocytes, and microglia harboring the frontotemporal dementia-associated MAPT IVS10+16 mutation and investigated how lncRNA dysregulation interfaces with tau pathology. Transcriptomic analyses revealed extensive cell-type specific lncRNA expression changes, with neurons exhibiting the greatest degree of mutation-associated remodeling. Comparative analyses with MAPT IVS10+16 patient brain tissue identified NORAD and MIR22HG as lncRNAs significantly dysregulated across all three cell types and human brains. NORAD was also altered in Alzheimer disease and Parkinson disease brains, suggesting a broader role in neurodegenerative disease. Mechanistically, NORAD-associated protein networks converged on pathways related to RNA regulation, cytoskeletal organization, proteostasis, and tau interaction networks. Given the established role of NORAD in regulating PUM1 and PUM2 RNA-binding (pumilio) proteins, we examined the NORAD-pumilio axis and identified enrichment of pumilio-associated pathways linked to autophagy, endocytosis, proteostasis, and cytoskeletal regulation. NORAD depletion reduced tau seeding and uptake, whereas functional depletion of PUM1 or PUM2 increased both processes, supporting an antagonistic relationship between NORAD and pumilio signaling in modulation of tau aggregation. Together, these findings identify widespread lncRNA dysregulation across neural cell types in the setting of a MAPT mutation and nominate the NORAD-pumilio axis as a regulatory pathway linking RNA homeostasis and tau propagation biology.
Open AccessThe NORAD-pumilio regulatory axis links lncRNA dysregulation to tau propagation-associated phenotypes
Long non-coding RNAs (lncRNAs) are increasingly implicated in neurodegenerative disease, yet their roles in tauopathy remain poorly understood. Here, we defined the lncRNA landscape across iPSC-derived neurons, astrocytes, and microglia harboring the frontotemporal dementia-associated MAPT IVS10+16 mutation and investigated how lncRNA dysregulation interfaces with tau pathology. Transcriptomic analyses revealed extensive cell-type specific lncRNA expression changes, with neurons exhibiting the greatest degree of mutation-associated remodeling. Comparative analyses with MAPT IVS10+16 patient brain tissue identified NORAD and MIR22HG as lncRNAs significantly dysregulated across all three cell types and human brains. NORAD was also altered in Alzheimer disease and Parkinson disease brains, suggesting a broader role in neurodegenerative disease. Mechanistically, NORAD-associated protein networks converged on pathways related to RNA regulation, cytoskeletal organization, proteostasis, and tau interaction networks. Given the established role of NORAD in regulating PUM1 and PUM2 RNA-binding (pumilio) proteins, we examined the NORAD-pumilio axis and identified enrichment of pumilio-associated pathways linked to autophagy, endocytosis, proteostasis, and cytoskeletal regulation. NORAD depletion reduced tau seeding and uptake, whereas functional depletion of PUM1 or PUM2 increased both processes, supporting an antagonistic relationship between NORAD and pumilio signaling in modulation of tau aggregation. Together, these findings identify widespread lncRNA dysregulation across neural cell types in the setting of a MAPT mutation and nominate the NORAD-pumilio axis as a regulatory pathway linking RNA homeostasis and tau propagation biology.
- Open Access
Integrative Genomic and Functional Analyses Reveal NINL as a Modulator of Tau Aggregation
Introduction: Proteostasis dysfunction is a hallmark of frontotemporal dementia (FTD) and Alzheimer’s disease (AD), yet the genetic and molecular pathways that disrupt protein homeostasis remain poorly understood. Methods: We integrated human genetics, transcriptomics, and functional studies to identify proteostasis network components involved in tauopathy. Results: We identified 18 proteostasis network genes harboring 75 rare, damaging variants enriched in FTD and/or AD. These genes, spanning multiple proteostasis pathways, were differentially expressed in MAPT mutant neurons and dysregulated in FTD and AD brains. NINL, which encodes Nlp, emerged as the only gene consistently upregulated across all datasets. NINL overexpression reduced tau seeding and enhanced lysosomal proteolytic activity, whereas two FTD-enriched NINL frameshift variants impaired Nlp expression and abolished these protective effects. Discussion: Our findings identify a set of proteostasis genes with genetic and transcriptional links to neurodegeneration and reveal NINL as a novel regulator of tau aggregation, potentially upregulated as an adaptive response to proteotoxic stress.
Open AccessIntegrative Genomic and Functional Analyses Reveal NINL as a Modulator of Tau Aggregation
Introduction: Proteostasis dysfunction is a hallmark of frontotemporal dementia (FTD) and Alzheimer’s disease (AD), yet the genetic and molecular pathways that disrupt protein homeostasis remain poorly understood. Methods: We integrated human genetics, transcriptomics, and functional studies to identify proteostasis network components involved in tauopathy. Results: We identified 18 proteostasis network genes harboring 75 rare, damaging variants enriched in FTD and/or AD. These genes, spanning multiple proteostasis pathways, were differentially expressed in MAPT mutant neurons and dysregulated in FTD and AD brains. NINL, which encodes Nlp, emerged as the only gene consistently upregulated across all datasets. NINL overexpression reduced tau seeding and enhanced lysosomal proteolytic activity, whereas two FTD-enriched NINL frameshift variants impaired Nlp expression and abolished these protective effects. Discussion: Our findings identify a set of proteostasis genes with genetic and transcriptional links to neurodegeneration and reveal NINL as a novel regulator of tau aggregation, potentially upregulated as an adaptive response to proteotoxic stress.
- Open Access
- 1 November 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 28 (11) , 4489
Mutant tau and stress lead to downregulation of long noncoding RNA, SNHG8
- 1 November 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 28 (11) , 4489
Open AccessMutant tau and stress lead to downregulation of long noncoding RNA, SNHG8
- Open Access
- 7 January 2021
- Published by Springer Nature
NPC to Astrocyte Differentiation v1
Here, we provide a detailed protocol for differentiation of human induced pluripotent stem cell derived neural progenitor cells into astrocytes.
- 7 January 2021
- Published by Springer Nature
Open AccessNPC to Astrocyte Differentiation v1
Here, we provide a detailed protocol for differentiation of human induced pluripotent stem cell derived neural progenitor cells into astrocytes.
- Open Access
- 3 September 2020
- Published by Springer Nature
Differentiation of iPSC into Microglia-Like Cells (iMGL) v2
This protocol outlines the derivation of Hematopoietic Progenitor Cells and differentiation of iMGLs using iPSC cultures. This protocol is modified the following papers.
- 3 September 2020
- Published by Springer Nature
Open AccessDifferentiation of iPSC into Microglia-Like Cells (iMGL) v2
This protocol outlines the derivation of Hematopoietic Progenitor Cells and differentiation of iMGLs using iPSC cultures. This protocol is modified the following papers.
- Open Access
- 26 May 2020
- Published by Springer Nature
Thawing, Expanding, and Freezing Human Fibroblasts v1
Thawing, Expanding, and Freezing Human Fibroblasts protocol (method) by Celeste Karch
- 26 May 2020
- Published by Springer Nature
Open AccessThawing, Expanding, and Freezing Human Fibroblasts v1
Thawing, Expanding, and Freezing Human Fibroblasts protocol (method) by Celeste Karch
- Open Access
- 27 April 2020
- Published by Springer Nature
Footprint-Free Genome Editing of iPSC Using Alt-R CRISPR/Cas9 v1
Footprint-Free Genome Editing of iPSC Using Alt-R CRISPR/Cas9 protocol (method) by Celeste Karch
- 27 April 2020
- Published by Springer Nature
Open AccessFootprint-Free Genome Editing of iPSC Using Alt-R CRISPR/Cas9 v1
Footprint-Free Genome Editing of iPSC Using Alt-R CRISPR/Cas9 protocol (method) by Celeste Karch
- Open Access
- 15 April 2020
- Published by Springer Nature
Differentiation of iPSC into Microglia-Like Cells (iMGL) v1
This protocol outlines the derivation of Hematopoietic Progenitor Cells and differentiation of iMGLs using iPSC cultures. This protocol is modified the following papers.
- 15 April 2020
- Published by Springer Nature
Open AccessDifferentiation of iPSC into Microglia-Like Cells (iMGL) v1
This protocol outlines the derivation of Hematopoietic Progenitor Cells and differentiation of iMGLs using iPSC cultures. This protocol is modified the following papers.
- Open Access
- 22 November 2019
- Published by Springer Nature
iPSC Cell Culture – Maintenance and Expansion v1
This protocol is about Maintenance and Expansion of induced pluripotent stem cells.
- 22 November 2019
- Published by Springer Nature
Open AccessiPSC Cell Culture – Maintenance and Expansion v1
This protocol is about Maintenance and Expansion of induced pluripotent stem cells.